Pharmaceuticals

Chifeng Pharmaceutical Co., Ltd. is a high-tech company dedicated to R&D, manufacturing and marketing of vitamins, antibiotics and intermediates which located in Chifeng, Inner Mongolia. It has successfully passed inspections by CFDA, USFDA and EDQM etc. Chifeng develops green process to meet state environmental protection regulations. Chifeng is continuously investing in R&D and technology innovations to provide high quality products and professional services to customers and partners all over the world.

Livzon is a comprehensive pharmaceutical enterprise integrating development & research, production and sales of pharmaceutical products, ranking 9 at Top 50 Pharmaceutical companies in China, ranking 8 at Top 10 listed pharmaceutical companies with the highest R&D investment. Livzon Group API Division established June 2015, is dedicated in the R&D, manufacturing and sales of API, including 4 manufacturing sites, Livzon Fuzhou Fuxing, Livzon New North River, Livzon Ningxia and Livzon Syntpharm. Most of the manufacturing sites have been approved by US FDA. And most of the products in regulatory markets have obtained CEP.

Thanks to the experience gained through over seventy years of work, A. Constantino & C. S.p.A. is today numbered among the world's largest producers of raw materials of animal and vegetable origin or top- level pharmaceutical use. Over the years, the company's horizons have expanded beyond national frontiers, and clients today include some of the world's best-known pharmaceutical companies. This expansion has also enabled the company to broaden its range of production, today comprising the categories enzymes for pharmaceutical and industrial use, animal organ extracts for pharmaceutical use, peptones and protein hydrolysates for industrial fermentation and for microbiology. A vital factor running right through A. Costantino & C. S.p.A.'s success story has been the emphasis the company has always placed on quality products. In 1997 this policy was rewarded by Quality Certification to the ISO 9001:2008 (Certiquality) nr.1086. For A. Costantino & C. S.p.A., the search for quality does not only mean successfully meeting market demands, rather that the company is continually renewed and updated, seeking to offer clients a product of high technological standard and service in line with their highly specific needs, as well as guaranteeing constant quality

Hebei Shengxue Dacheng Pharmaceuticat Co., Ltd founded in 1997, is a large pharmaceutical company focusing on producing and marketing antibiotics, feed additives and premixes. Our company is state owned and subordinate to China National Nuclear Corporation. We set up two wholly-owned subsidiaries - Hebei Shengxue Dacheng Pharmaceutical (Tangshan) Co., Ltd and Hebei Hongcheng Yaxin Technology Co.,Ltd.

Nantong Jinghua Pharmaceutical Co.,Ltd is a public pharmaceutical company in China that was established in 1957, owning about 302 staffs, located in No. 20, 3 Haibin Road, Yanhai Economic Development Zone, Rudong, Nantong Jiangsu, China. We are appointed as a high-new-technical enterprise by Jiangsu Scientific technological Bureau. As a comprehensive, advanced and innovative GMP company, we focus on manufacture, R&D and sales of APIs, pharmaceutical intermediates. Our company produce Phenobarbital, Primidone, Fluorouracil, Phenylbutazone, Flucytosine, Piroxicam, and Propylthiouracil etc., in which the first five products have CEP certificates.

Established in 1996, North China Pharmaceutical Group Aino Co., Ltd. is located in the Economic and Technical Development zone, Shijiazhuang, Hebei Province, P.R. China. During these years North China Pharmaceutical Group Aino Co., Ltd has been majoring in developing, manufacturing and selling green APIs. As Aino’s leading product, ABAMECTIN and IVERMECTIN are widely used as the most effective and broad-spectrum insecticides in the world. AINO produces strictly in accordance with GMP standards and become the first batch of China abamectin companies allowed to enter the United States and Europe market.

NCPC Huasheng is one of subsidiaries of NCPC. It was established in 1995, and production began in 1996. •More than 20 years dedicated in the manufacturing of APIs •Floor area: 85,000m2 •Personel: about 1,000peoples

NORTH CHINA PHARMACEUTICAL GROUP SEMISYNTECH CO., LTD is a wholly-owned subsidiary of NCPC, which is specialized in manufacturing and sales of penicillin series products including pharmaceutical intermediates and APIs. The company is located in economic & technical development zone of Liangcun, Shijiazhuang.